ATE383371T1 - Ptprk-immunogenes peptid - Google Patents

Ptprk-immunogenes peptid

Info

Publication number
ATE383371T1
ATE383371T1 AT03789032T AT03789032T ATE383371T1 AT E383371 T1 ATE383371 T1 AT E383371T1 AT 03789032 T AT03789032 T AT 03789032T AT 03789032 T AT03789032 T AT 03789032T AT E383371 T1 ATE383371 T1 AT E383371T1
Authority
AT
Austria
Prior art keywords
ptprk
immunogene
peptide
immunogene peptide
diagnosis
Prior art date
Application number
AT03789032T
Other languages
English (en)
Inventor
Chiara Castelli
Giorgio Parmiani
Original Assignee
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Naz Stud Cura Dei Tumori filed Critical Ist Naz Stud Cura Dei Tumori
Application granted granted Critical
Publication of ATE383371T1 publication Critical patent/ATE383371T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70539MHC-molecules, e.g. HLA-molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/5743Specifically defined cancers of skin, e.g. melanoma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5154Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • A61K2039/876Skin, melanoma
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03789032T 2002-11-14 2003-11-12 Ptprk-immunogenes peptid ATE383371T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002412A ITMI20022412A1 (it) 2002-11-14 2002-11-14 Peptidi immunogeni di ptprk.

Publications (1)

Publication Number Publication Date
ATE383371T1 true ATE383371T1 (de) 2008-01-15

Family

ID=32310164

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03789032T ATE383371T1 (de) 2002-11-14 2003-11-12 Ptprk-immunogenes peptid

Country Status (12)

Country Link
US (1) US20060159691A1 (de)
EP (1) EP1560848B1 (de)
JP (1) JP2006506064A (de)
AT (1) ATE383371T1 (de)
AU (1) AU2003293677A1 (de)
DE (1) DE60318608T2 (de)
DK (1) DK1560848T3 (de)
ES (1) ES2299748T3 (de)
HK (1) HK1076476A1 (de)
IT (1) ITMI20022412A1 (de)
PT (1) PT1560848E (de)
WO (1) WO2004043988A2 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863755A (en) * 1993-04-21 1999-01-26 Max Planck Gessellschaft Nucleic acid encoding novel receptor-type phosphotyrosine phosphatase-κ

Also Published As

Publication number Publication date
WO2004043988A8 (en) 2005-08-25
JP2006506064A (ja) 2006-02-23
DE60318608D1 (de) 2008-02-21
EP1560848A2 (de) 2005-08-10
ES2299748T3 (es) 2008-06-01
WO2004043988A3 (en) 2004-10-14
DE60318608T2 (de) 2009-01-15
WO2004043988A2 (en) 2004-05-27
HK1076476A1 (en) 2006-01-20
EP1560848B1 (de) 2008-01-09
US20060159691A1 (en) 2006-07-20
DK1560848T3 (da) 2008-05-26
ITMI20022412A1 (it) 2004-05-15
AU2003293677A1 (en) 2004-06-03
PT1560848E (pt) 2008-04-08

Similar Documents

Publication Publication Date Title
CY1114855T1 (el) Αντισωματα και μορια που προερχονται απο αυτα που δεσμευονται στις πρωτεϊνες toy steap-1
HK1093014A1 (en) Microsome vaccine
CY1113044T1 (el) Παραλλαγματα αντιγονου αρχεγονων κυτταρων προστατη (psca) και υποαλληλουχιες εξ αυτων
MXPA05008128A (es) Peptidos derivados de survivina y uso de los mismos.
PE20040554A1 (es) Vacunas que comprenden proteinas de fusion
CY1114944T1 (el) Σταθεροποιημενα αλφα ελικοειδη πεπτιδια και χρησεις αυτων
PE20050712A1 (es) Anticuerpos rg1
WO2001055393A3 (en) Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
WO2002064057A3 (en) Use of cell penetrating peptides to generate antitumor immunity
ATE457352T1 (de) Subtilisin-carlsberg-proteine mit verminderter immunogenität
ATE517340T1 (de) Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
DE60315827D1 (de) Verbesserte polysaccharid- und glykokonjugat-vakzine
TR200102034T2 (tr) Anti kanser aşılaması için antikorların kullanılması
DE60118359D1 (de) Humanische pellino-polypeptide
AU2003241127A1 (en) MEMBRANE-ANCHORED Beta2 MICROGLOBULIN COVALENTLY LINKED TO MHC CLASS I PEPTIDE EPITOPES
DE69720065D1 (de) Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen
AU7615900A (en) Isolated peptides which bind to mhc class ii molecules, and uses thereof
UY26266A1 (es) Antigeno asociado con tumores (r11) ley 17164
AU2003245781A1 (en) Mhc class ii peptide epitope of 5t4 antigen
ATE383371T1 (de) Ptprk-immunogenes peptid
HUP0300997A2 (hu) A MIA-fehérje alkalmazása immunterápiában
DK0996636T3 (da) HA-1-antigenet
DK1578772T3 (da) Cytokiner og cytokinreceptorer med reduceret immunogenicitet
AR026068A1 (es) Peptidos modificados y peptidomimeticos para el uso en inmunoterapia.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1560848

Country of ref document: EP

REN Ceased due to non-payment of the annual fee